Literature DB >> 18324486

Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis.

A Bossowski1, B Czarnocka, K Bardadin, A Stasiak-Barmuta, M Urban, J Dadan, K Ratomski, A Bossowska.   

Abstract

Apoptosis, i.e. natural programmed cell death, is a physiological phenomenon indispensable for normal functioning of the organism. The signal to apoptosis can be started practically in any cell. Disturbances in the apoptosis regulation determine the essential link of the pathogenesis of many diseases, including autoimmune thyroid disorders. The aim of the study was to assess the expression of Fas/FasL and caspase eight in the tissues of the thyroid gland in patients with Graves' disease (GD), non-toxic nodular goiter (NTNG) and Hashimoto's thyroiditis (HT). The analysis of Fas/FasL expression was performed by western blot and immunohistochemical investigation with DAB-visualization and Mayer's hematoxylin staining. Caspase-8 expression in thyroid follicular cells was assayed by western blot method. Identification of the proapoptotic proteins FasL and Fas exhibited their pronounced expression in the thyroid tissue in GD patients (++; ++) and HT (+++; +++) as compared to the NTNG group (0/+; 0/+). Among the study groups, the expression of caspase-8 was revealed in band 55 kDa from patients with autoimmune thyroid diseases. In GD patients, the percentage of thyrocytes with FasL expression correlated positively with TRAb (R = 0.58, p < 0.02). However, no such correlations were noted in HT or non-toxic multinodular goiter. There were no significant correlations between thyroid hormones and the percentage of thyrocytes with Fas and FasL expression. In conclusion, our findings suggest that the changes in the expression of apoptotic molecules on the surface of T lymphocytes and thyroid follicular cells in patients with autoimmune thyroid disorders reflect their substantial involvement in the pathogenesis of GD and HT. In addition, analysis of Fas/FasL and caspase-8 expression in thyroid tissue may indicate the disease activity and immunological phenotype.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18324486     DOI: 10.1080/08916930701727749

Source DB:  PubMed          Journal:  Autoimmunity        ISSN: 0891-6934            Impact factor:   2.815


  12 in total

1.  How one TSH receptor antibody induces thyrocyte proliferation while another induces apoptosis.

Authors:  Syed A Morshed; Risheng Ma; Rauf Latif; Terry F Davies
Journal:  J Autoimmun       Date:  2013-08-17       Impact factor: 7.094

Review 2.  Delineating the autoimmune mechanisms in Graves' disease.

Authors:  Syed A Morshed; Rauf Latif; Terry F Davies
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

3.  Neuroprotective effect of (-)-epigallocatechin-3-gallate on autoimmune thyroiditis in a rat model by an anti-inflammation effect, anti-apoptosis and inhibition of TRAIL signaling pathway.

Authors:  Junfeng Li
Journal:  Exp Ther Med       Date:  2017-11-14       Impact factor: 2.447

4.  Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades.

Authors:  Syed A Morshed; Takao Ando; Rauf Latif; Terry F Davies
Journal:  Endocrinology       Date:  2010-09-15       Impact factor: 4.736

5.  A genetic risk score for thyroid peroxidase antibodies associates with clinical thyroid disease in community-based populations.

Authors:  Ulla T Schultheiss; Alexander Teumer; Marco Medici; Yong Li; Natalie Daya; Layal Chaker; Georg Homuth; Andre G Uitterlinden; Matthias Nauck; Albert Hofman; Elizabeth Selvin; Henry Völzke; Robin P Peeters; Anna Köttgen
Journal:  J Clin Endocrinol Metab       Date:  2015-02-26       Impact factor: 5.958

6.  A newly identified TSHβ splice variant is involved in the pathology of Hashimoto's thyroiditis.

Authors:  Chunrong Liu; Lanying Li; Fan Ying; Cangdan Xu; Xiaoyi Zang; Zhihong Gao
Journal:  Mol Biol Rep       Date:  2012-07-03       Impact factor: 2.316

7.  Autoimmune thyroiditis in antinuclear antibody positive children without rheumatologic disease.

Authors:  Kathryn S Torok; Thaschawee Arkachaisri
Journal:  Pediatr Rheumatol Online J       Date:  2010-05-05       Impact factor: 3.054

Review 8.  Graves' Disease Mechanisms: The Role of Stimulating, Blocking, and Cleavage Region TSH Receptor Antibodies.

Authors:  S A Morshed; T F Davies
Journal:  Horm Metab Res       Date:  2015-09-11       Impact factor: 2.936

9.  High Serum IgG4 Concentrations in Patients with Hashimoto's Thyroiditis.

Authors:  Anna Popławska-Kita; Maria Kościuszko-Zdrodowska; Katarzyna Siewko; Beata Telejko; Justyna Hryniewicka; Robert Milewski; Saeid Soleman Abdelrazek; Małgorzata Szelachowska; Maria Górska
Journal:  Int J Endocrinol       Date:  2015-02-16       Impact factor: 3.257

10.  Identification of novel genetic Loci associated with thyroid peroxidase antibodies and clinical thyroid disease.

Authors:  Marco Medici; Eleonora Porcu; Giorgio Pistis; Alexander Teumer; Suzanne J Brown; Richard A Jensen; Rajesh Rawal; Greet L Roef; Theo S Plantinga; Sita H Vermeulen; Jari Lahti; Matthew J Simmonds; Lise Lotte N Husemoen; Rachel M Freathy; Beverley M Shields; Diana Pietzner; Rebecca Nagy; Linda Broer; Layal Chaker; Tim I M Korevaar; Maria Grazia Plia; Cinzia Sala; Uwe Völker; J Brent Richards; Fred C Sweep; Christian Gieger; Tanguy Corre; Eero Kajantie; Betina Thuesen; Youri E Taes; W Edward Visser; Andrew T Hattersley; Jürgen Kratzsch; Alexander Hamilton; Wei Li; Georg Homuth; Monia Lobina; Stefano Mariotti; Nicole Soranzo; Massimiliano Cocca; Matthias Nauck; Christin Spielhagen; Alec Ross; Alice Arnold; Martijn van de Bunt; Sandya Liyanarachchi; Margit Heier; Hans Jörgen Grabe; Corrado Masciullo; Tessel E Galesloot; Ee M Lim; Eva Reischl; Peter J Leedman; Sandra Lai; Alessandro Delitala; Alexandra P Bremner; David I W Philips; John P Beilby; Antonella Mulas; Matteo Vocale; Goncalo Abecasis; Tom Forsen; Alan James; Elisabeth Widen; Jennie Hui; Holger Prokisch; Ernst E Rietzschel; Aarno Palotie; Peter Feddema; Stephen J Fletcher; Katharina Schramm; Jerome I Rotter; Alexander Kluttig; Dörte Radke; Michela Traglia; Gabriela L Surdulescu; Huiling He; Jayne A Franklyn; Daniel Tiller; Bijay Vaidya; Tim de Meyer; Torben Jørgensen; Johan G Eriksson; Peter C O'Leary; Eric Wichmann; Ad R Hermus; Bruce M Psaty; Till Ittermann; Albert Hofman; Emanuele Bosi; David Schlessinger; Henri Wallaschofski; Nicola Pirastu; Yurii S Aulchenko; Albert de la Chapelle; Romana T Netea-Maier; Stephen C L Gough; Henriette Meyer Zu Schwabedissen; Timothy M Frayling; Jean-Marc Kaufman; Allan Linneberg; Katri Räikkönen; Johannes W A Smit; Lambertus A Kiemeney; Fernando Rivadeneira; André G Uitterlinden; John P Walsh; Christa Meisinger; Martin den Heijer; Theo J Visser; Timothy D Spector; Scott G Wilson; Henry Völzke; Anne Cappola; Daniela Toniolo; Serena Sanna; Silvia Naitza; Robin P Peeters
Journal:  PLoS Genet       Date:  2014-02-27       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.